Genmab | DEBITO



Debt Cambiamento Data
Agios Pharmaceuticals USD 0 0 2024-12
Almirall EUR 408.66M 56.36M 2024-06
Amarin USD 0 0 2024-09
Amgen USD 60.1B 299M 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Bayer EUR 40.7B 465M 2024-12
BioMarin Pharmaceutical USD 596.24M 1.61M 2024-12
Demant DKK 15.68B 146M 2024-12
Exelixis USD 0 0 2025-01
Fresenius Medical Care EUR 10.98B 225M 2024-12
Galapagos EUR 11.72M 257K 2024-12
Genmab DKK 1.03B 42M 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
GN Store Nord DKK 10.31B 1.25B 2024-12
GRIFOLS EUR 9.23B 626.05M 2024-12
Hikma Pharmaceutical USD 1.28B 85M 2024-06
Insmed USD 1.13B 147.86M 2024-12
Lonza CHF 4.71B 915M 2024-12
Merck EUR 11.38B 636M 2024-09
Novartis USD 31.26B 828M 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 23.75B 5.33B 2024-06
UCB EUR 3.03B 13M 2024-12



Genmab DEBITO - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.